Urgent.News

What's breaking now, across thousands of outlets.

Business

Novo CEO signals M&A opportunities to strengthen drug pipeline

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Business

More from Tuesday 22 September →